Show simple item record

dc.contributor.authorAnderson, Heatheren
dc.contributor.authorPetrie, Ken
dc.contributor.authorBerrisford, Cen
dc.contributor.authorCharlett, Aen
dc.contributor.authorThatcher, Nicken
dc.contributor.authorZambon, Men
dc.date.accessioned2010-07-12T15:40:50Z
dc.date.available2010-07-12T15:40:50Z
dc.date.issued1999-04
dc.identifier.citationSeroconversion after influenza vaccination in patients with lung cancer. 1999, 80 (1-2):219-20 Br J Canceren
dc.identifier.issn0007-0920
dc.identifier.pmid10389999
dc.identifier.doi10.1038/sj.bjc.6690342
dc.identifier.urihttp://hdl.handle.net/10541/107513
dc.description.abstractThere are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers.
dc.language.isoenen
dc.subjectLung Canceren
dc.subject.meshAged
dc.subject.meshAntibodies, Viral
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInfluenza Vaccines
dc.subject.meshInfluenza, Human
dc.subject.meshLung Neoplasms
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshVaccination
dc.titleSeroconversion after influenza vaccination in patients with lung cancer.en
dc.typeArticleen
dc.contributor.departmentMedical Oncology, Wythenshawe Hospital, Manchester, UK.en
dc.identifier.journalBritish Journal of Canceren
html.description.abstractThere are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers.


This item appears in the following Collection(s)

Show simple item record